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Summary
 
To study the contribution of endogenous myelin basic protein (MBP) to the positive and/or
negative selection of the MBP-specific T cell repertoire, we studied the T cell response to
MBP in MBP-deficient shiverer and MBP-expressing congenic C3H mice. Immunization
with MBP induced a vigorous T cell response in shiverer mice directed against a single I-A
 
k
 
–
restricted immunodominant determinant, the core of which is peptide MBP:79-87 (DENPV-
VHFF). Injection of this peptide induced a high avidity T cell repertoire in shiverer mice that
primarily consisted of clones capable of recognizing the native MBP protein in addition to the
peptide itself. These data show that endogenous MBP is not required for the positive selection
of an MBP-specific T cell repertoire. C3H mice, in contrast, were selectively unresponsive to
the MBP protein and injection of MBP:79-87 peptide induced a low avidity repertoire that
could be stimulated only by the peptide, not by the protein. Therefore, endogenous MBP in-
duced profound inactivation of high avidity clones specific for the immunodominant determi-
nant making that determinant appear cryptic.
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T
 
here have been three mechanisms implicated in the
development of self tolerance: clonal deletion, anergy,
and ignorance. At present, it is unclear which of these
mechanisms underlies the naturally developing self toler-
ance to myelin basic protein (MBP)
 
1
 
, an abundant central
nervous system protein and the best-studied autoantigen.
For decades it was thought that MBP is sequestered behind
the blood–brain barrier, but more recently MBP transcripts
have been detected in the thymus and in other lymphoid
organs (1–3), and evidence that MBP is presented in the
thymus has emerged (4). However, the extent to which en-
dogenous MBP contributes to the positive and/or negative
selection of the MBP-reactive T cell repertoire remained
unclear. Studies using three independently generated TCR
transgenic mice showed that MBP:Ac1-11–specific T cells
are positively selected in the thymi of MBP-expressing 
 
H-2
 
u
 
mice and, in the absence of cross-reactive environmental
stimulation, persist as naive T cells in their secondary lym-
phoid tissues (5–7). Although they do not yield conclusions
about the role of endogenous MBP in positive selection,
these results seemed to imply that the dominant determi-
nant of MBP does not cause clonal deletion in 
 
H-2
 
u
 
 mice
and that ignorance is the primary tolerance mechanism to
MBP. Only when activated by immunization or environ-
mental antigens would these MBP-reactive T cells induce
the inflammatory central nervous system (CNS) disease,
experimental allergic encephalomyelitis (EAE), an animal
model of human multiple sclerosis (8). In support of this
data, MBP-reactive T cells are present in unmanipulated,
healthy mice, but these T cells do not cause EAE without
immunization with MBP and treatment with pertussis
toxin to open up the blood brain barrier (9). Do such T
cells in MBP-expressing hosts represent the full MBP-reac-
tive repertoire or are they low avidity remnants that slipped
through the negative selection process? How fully do the
existing TCR-transgenic models reflect the mechanisms of
self tolerance to MBP?
We studied the contribution of endogenous MBP to
positive and negative selection by comparing the MBP-
specific T cell repertoires in MBP-deficient Shiverer mice
(
 
H-2
 
k
 
) and in the congenic, MBP-expressing C3H strain.
Shiverer mice have a deletion in the last five exons of the
MBP gene; the first two MBP exons are present but their
transcripts are unstable (10, 11). We report here, first, that,
shiverer mice can generate a vigorous high avidity T cell
response to MBP and its immunodominant determinant
suggesting that endogenous MBP is not required for the
positive selection of MBP-reactive T cells. Second, we re-
 
1
 
Abbreviations used in this paper:
 
 CNS, central nervous system; EAE, exper-
imental allergic encephalomyelitis; HEL, hen eggwhite lysozyme; MBP,
myelin basic protein; gpMBP, guinea pig MBP; mMBP, mouse MBP.
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T Cell Repertoire in 
 
MBP
 
1
 
/
 
1
 
 and 
 
MBP
 
2
 
/
 
2
 
 Mice
 
port that the MBP-expressing C3H mice are selectively
unresponsive to this protein and its immunodominant pep-
tide, but retain low avidity MBP-reactive T cells. There-
fore, endogenous MBP induces profound clonal inactiva-
tion of the high avidity MBP-reactive T cell repertoire.
When 
 
H-2
 
u
 
 mice (which express MBP) are immunized
with MBP, Ac1-11 is the peptide that elicits the strongest
immune response and, hence, has been defined as the im-
munodominant determinant for this haplotype (12, 13).
When the inflammatory CNS lesions develop, additional
MBP peptides are targeted by T cells; these include the
peptide 121–141, which has been designated as cryptic (14,
15). This assignment of determinant hierarchy has defined
the immunotherapeutic approach to the EAE model. It as-
sumes that determinant hierarchy within the T cell response
to MBP follows the rules of T cell responses to foreign an-
tigens, where the most abundantly presented peptide is likely
to be the immunodominant one (16, 17). However, if en-
dogenous MBP induces tolerance, its dominant determinant(s)
might be the one that inactivates T cells most efficiently, as
was observed after tolerogenic injection of hen egg lysozyme
protein (18) and the transgenic expression of that protein
(19). If the MBP-specific T cell repertoire were shaped in a
similar fashion by endogenous MBP, one might expect the
determinant that is immunodominant in the MBP-deficient
shiverer mouse to be a cryptic determinant in the MBP-
expressing congenic strain. Here we report evidence for
this apparent reversal of determinant hierarchy.
 
Materials and Methods
 
Mice, Antigens, and Immunizations.
 
Shiverer C3HeB/FeJ-
 
Mbp
 
shi
 
/
 
1
 
mice, congenic C3HeB/FeJ mice, and B10.A(2R) and B10.A(4R)
mice were purchased from The Jackson Laboratories (Bar Har-
bor, ME) and bred at CWRU facilities under specific pathogen-
free conditions. Hen eggwhite lysozyme (HEL) and ovalbumin
(OVA) were purchased from Sigma Chemical Co. (St. Louis,
MO). Guinea pig MBP (gpMBP) and mouse MBP (mMBP)
were prepared as described (20). MBP:79-87 peptide (DENPV-
VHFF) was purchased from Princeton Biomolecules (Columbus,
OH). IFA was purchased from GIBCO BRL (Gaithersburg, MD)
and CFA was made by adding 
 
Mycobacterium tuberculosis 
 
H37RA
(Difco Laboratories, Detroit, MI) at 2 mg/ml to IFA. Individu-
ally, antigens or peptides were mixed with the adjuvant to yield
the emulsions, 50 
 
m
 
l of which were administered in a single in-
jection. The antigen/peptide dose deposited within the injection
is specified in the text and figure legends.
 
Cytokine ELISA Spot Assays.
 
Plates (ImmunoSpot
 
Ò
 
; Autoim-
mun Diagnostika (US) Inc., Beltsville, MD) were coated over-
night at 4
 
8
 
C with the cytokine-specific capture antibodies speci-
fied below. The plates were then blocked with 1% BSA in PBS
for 1 h at room temperature and washed 4
 
3
 
 with PBS. Subse-
quently, the antigens, peptides, and freshly isolated single cell sus-
pensions of spleen or LN cells were added under the conditions
specified for proliferation assays. After 24–48 h of cell culture in
the incubator, the cells were removed by washing 3
 
3
 
 with PBS
and 4
 
3
 
 with PBS containing 0.05% Tween (PBST), then the de-
tection antibodies were added and incubated at 4
 
8
 
C overnight
(the detection antibodies were either HRP-labeled or biotiny-
lated). The plates were washed 3
 
3
 
 with PBST. If biotinylated
 
detection mAbs were used, streptavidin-HRP conjugate (Dako
Corp., Carpenteria, CA) was added at 1:3,000 dilution, incubated
for 2 h at room temperature, and removed by washing twice with
PBST and twice with PBS. The spots were visualized by adding
HRP substrate AEC (3amino-9-ethylcarbozole) (Pierce Chemi-
cal Co., Rockford, IL). We used the following combinations of
capture and detection mAbs for IL-2, IL-4, IL-5, and IFN-
 
g
 
 as-
says, respectively: JES6-1A12 (5 
 
m
 
g/ml) and JES6-5H4-biotin (2
 
m
 
g/ml), BVD4-1D11 (2 
 
m
 
g/ml) and BVD4-24G2-biotin (2.5
 
m
 
g/ml), TRFK5 (5 
 
m
 
g/ml) and TRFK4-HRP (2 
 
m
 
g/ml), and
R46A2 (5 
 
m
 
g/ml) and XMG1.2-HRP (2 
 
m
 
g/ml). Image analysis
of ELISA spot assays was performed on a Series 1 ImmunoSpot
 
Ò
 
Image Analyzer (Autoimmun Diagnostika (US) Inc.) customized
for analyzing ELISA spots to meet objective criteria for size,
chromatic density, shape and color.
 
Proliferation Assays.
 
Spleen cell proliferation assays were per-
formed as previously described (14). In brief, single cell suspen-
sions were prepared and 1 
 
3
 
 10
 
6
 
 spleen cells per well were plated
in flat-bottom 96-well microtiter plates in serum-free HL-1 me-
dium (BioWhittaker, Inc., Walkersville, MD) supplemented with
 
L
 
-glutamine at 1 mM. Antigens and peptides were added at the
final concentrations specified in the text and legends. During the
last 18 h of a 4-d culture, [
 
3
 
H]thymidine was added (1 
 
m
 
Ci/well);
incorporation of label was measured by liquid scintillation count-
ing. Assays of LN followed the same protocol except that 5 
 
3
 
 10
 
5
 
cells were plated per well. CTLL proliferation assays for measur-
ing IL-2 production by antigen-activated T cell hybridomas were
performed according to standard protocols. In brief, 5 
 
3
 
 10
 
4
 
 T
cell hybridomas and 5 
 
3 
 
10
 
5
 
 irradiated spleen cells were plated
per well with or without antigen. After 24 h in cell culture, 50 
 
m
 
l
of supernatant was collected and frozen at 
 
2
 
85
 
8
 
C until tested for
their ability to induce CTLL cells (1 
 
3
 
 10
 
4
 
/well) to proliferate
for 24 h. [
 
3
 
H]Thymidine (1 
 
m
 
Ci/well) was added for the last 16 h
of the assay; incorporation of label was measured by liquid scintil-
lation counting.
 
Determinant Mapping with Overlapping Peptides.
 
A series of non-
amer peptides covering the entire murine MBP sequence in steps
of single amino acids (Chiron Mimotopes, Raleigh, NC) were
dissolved at 560 
 
m
 
M in pH-optimized buffer (either 0.2 M Hepes
or 0.2 M acetic acid) and aliquoted into 96-well plates and stored
frozen at 
 
2
 
85
 
8
 
C. Freshly thawed peptides were tested at 7 
 
m
 
M
in the ELISA spot and proliferation assays, as described.
 
Generation of T Cell Hybridomas.
 
T cell hybridomas from shiverer
and C3H mice were generated using a standard protocol (21). In
brief, 9 d after immunization with 50 
 
m
 
g of MBP peptide 79–87
in CFA, subcutaneously, draining LN cells were activated in vitro
with 50 
 
m
 
M MBP:79-87 as specified for proliferation assays. After
78 h, 10 ng/ml of recombinant human IL-2 (a gift from Sandoz
Ltd., Basel, Switzerland) was added overnight and the cells were
fused with BW1100 T lymphoma cells (provided by Dr. C. Har-
ding, Case Western Reserve University, Cleveland, OH). The
cells were plated under limiting dilution conditions. The resulting
hybrids were tested for MBP:79-87 specificity in CTLL assays
and positive hybridomas were recloned under conditions of limit-
ing dilution. Restriction of the hybridomas was mapped using re-
combinant mouse strains and the 
 
I-A
 
k
 
–transfected cell line C3F6
(22), the 
 
H-2
 
 allele expression of which is shown in Fig. 1 
 
B
 
.
 
Results
 
MBP
 
2
 
/
 
2
 
 Mice Respond to MBP, but MBP
 
1
 
/
 
1
 
 Mice Do
Not.
 
We immunized C3H (
 
MBP
 
1
 
/
 
1
 
) and congenic shiv-
erer (
 
MBP
 
2
 
/
 
2
 
) mice with two control “foreign” antigens, 
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OVA and HEL, and tested the antigen-specific recall re-
sponse in draining LN. We performed cytokine ELISA
spot assays to measure the frequency of antigen-specific T
cells in freshly primed cell populations. The magnitude of
the IFN-
 
g
 
 recall response to these control antigens was
comparable in C3H and shiverer mice (Table 1). The im-
munizations with OVA and HEL also induced similar fre-
quencies of memory cells that produced IL-2 but did not
induce detectable production of IL-4 or IL-5 (data not
shown). These data show that C3H and shiverer mice
mount type-1 responses of comparable magnitudes to two
prototypic “foreign antigens”; despite their neurologic de-
fect, shiverer mice are fully immunocompetent.
When immunized with either mMBP or gpMBP (the
two proteins differ at 15 residues scattered over the 168–
amino acid sequence), shiverer mice developed a vigorous
response that could be recalled with either protein (Table
1). As with the aforementioned control antigens, IL-2 was
detected in addition to IFN-
 
g
 
, a result confirmed in prolif-
eration assays, whereas neither IL-4 or IL-5 was detected
(data not shown). In two experiments performed using
Shiverer mice (six mice per group), the frequency of the
MBP-specific IFN-
 
g
 
–producing memory cells was three to
eight times higher in MBP-immunized shiverer mice than
the frequency of memory T cells specific for HEL or OVA
in mice immunized with the respective antigen (Table 1).
Because C3H mice are classic high responders for HEL and
OVA, these data show that mice of the C3H (
 
H-2
 
k
 
) back-
ground are high-responders to MBP when MBP is a “for-
eign” antigen.
Unlike the case in shiverer mice, mMBP did not induce
an IFN-
 
g
 
 recall response in C3H mice (Table 1), nor was
MBP-specific proliferation or the production of IL-2, IL-4,
or IL-5 detected in immunized mice (data not shown). Im-
munization with gpMBP resulted in a response that was
not recalled with mMBP (Table 1). Despite the extensive
sequence similarities between the two proteins, the anti-
gpMBP response did not cross-react with mMBP but
seemed to be directed against the species-foreign sequences
of the protein. In light of the fact that 
 
MBP
 
2
 
/
 
2
 
 mice re-
spond strongly to mMBP, the complete absence of sponta-
neous mMBP-reactivity in the unimmunized 
 
MBP
 
1
 
/
 
1
 
mice suggests that endogenous MBP did not prime a type-2
immune response, that is, the spontaneous development of
tolerance to MBP did not involve immune deviation. In-
stead, the failure of C3H mice to respond to mMBP even
after immunization with gpMBP suggests that their endog-
enous MBP had inactivated the majority of MBP-reactive
precursor T cells.
IFN-
 
g
 
 responses to MBP (Table 1) were not detected in
C3H or shiverer mice immunized with control antigens,
nor was production of IL-2, IL-4, or IL-5 or a proliferative
response seen (data not shown). Exposure to potentially
cross-reactive environmental antigens did not, therefore,
result in significant spontaneous priming of MBP-reactive
T cells.
 
MBP Peptide 79–87 Is the Core Immunodominant Determi-
nant in Shiverer Mice.
 
We immunized shiverer mice with
mMBP and mapped the fine specificity of the response us-
ing an overlapping nonamer peptide series. Fig. 1 
 
A
 
 shows
that, from the entire series, only three peptides induced a
recall-response, 78–86, 79–87, and 80–88, with the re-
sponse to peptide 79–87 by far the strongest. No reactions
were detected to other peptides, including peptide Ac1-11,
which has been defined as an I-A
 
k
 
–restricted determinant
(23). This result identifies peptide 79–87 on the MBP mol-
ecule as the core immunodominant determinant in shiverer
mice. Further characterization showed that this MBP:79-
87–specific recall response could be blocked with anti-
CD4 mAb (data not shown) and that this peptide is I-A
 
k
 
–
restricted (Fig. 1 
 
B
 
).
Immunization of C3H mice with mMBP (or with gp-
MBP) did not result in a recall response to any of the
mMBP peptides (Fig. 1 
 
A
 
); therefore, the MBP:79-87 pep-
tide that was immunodominant in the 
 
MBP
 
2
 
/
 
2
 
 mouse was
non-stimulatory in the congenic, 
 
MBP
 
1
 
/
 
1
 
 strain after the
injection of the MBP protein.
 
The Functional MBP:79-87–specific T Cell Repertoire Is of
High Avidity in MBP
 
2
 
/
 
2
 
 Mice and of Low Avidity in MBP 
 
1
 
/
 
1
 
Mice.
 
Negative selection was shown to primarily affect T
cell clones with high avidity and spare those with low avid-
ity (24). To address this possibility, we tested the dose-
response characteristics of the MBP:79-87 peptide-specific
functional T cell repertoires in shiverer and C3H mice.
Groups of mice from each strain were immunized with 50,
5, or 0.5 
 
m
 
g of the MBP:79-87 peptide, and their draining
LN were tested in cytokine ELISA spot assays titrating the
peptide’s concentration in the recall culture (Fig. 2 
 
A
 
). Im-
munizing shiverer mice with 50 
 
m
 
g of the peptide primed a
vigorous IFN-
 
g
 
 recall response that had a dose response
curve that plateaued at 10
 
2
 
4
 
 M of MBP:79-87 and induced
IFN-
 
g
 
 production in 365 cells of the one million LN cells
tested (cells producing IL-4 and IL-5 were not detected,
 
Table 1.
 
Immunogenicity of MBP in Shiverer vs. C3H Mice
 
Immunization
 
*
 
Antigen-Induced
 
‡
 
 IFN-
 
g
 
 spots
 
§
 
Mice Antigen Medium mMBP gpMBP OVA HEL
Shiverer mMBP ,3 81 6 7 181 6 40 ,3 ,3
(MBP2/2) gpMBP ,3 83 6 20 227 6 95 ,3 ,3
OVA ,3 ,3 ,3 31 6 13 ,3
HEL ,3 ,3 ,3 ,3 12 6 1
C3H mMBP ,3 ,3 ,3 ,3 ,3
(MBP1/1) gpMBP ,3 ,3 23 6 5 ,3 ,3
OVA ,3 ,3 ,3 21 6 4 ,3
HEL ,3 ,3 ,3 ,3 11 6 4
*50 mg/mouse in CFA, subcutaneously.
‡50 mg/ml
§Number of spots/million draining lymph node cells tested on day 9 by
IFN-g ELISA spot (mean 6 SE for three mice per group tested in two
experiments). SD for triplicate wells for individual mice was ,10%.2058 T Cell Repertoire in MBP1/1 and MBP2/2 Mice
data not shown). In C3H mice, on the contrary, the 50 mg
immunization dose primed 19 IFN-g–producing cells per
million LN cells when tested at the same 1024 M MBP:79-
87 recall concentration, the highest that was not toxic to
the cells. No cells producing IL-4 or IL-5 were detected.
The dose–response curve in C3H mice did not approxi-
mate a plateau and, compared with that of shiverer mice,
was shifted 4 Log units to the right. Immunizations with
the 0.5 mg MBP:79-87 peptide dose still primed a vigorous
response in shiverer mice but failed to induce a significant
response in the C3H strain; the 5 mg immunizing dose
gave intermediate results.
Figure 1. Mapping of the MBP response in shiverer mice. (A) Fine
specificity of the response. Shiverer mice (open bars) and C3H mice (filled
bars) were immunized with 50 mg mMBP in CFA, subcutaneously. 10 d
later, the draining LN and spleen cells of three mice in each group were
pooled and tested by IFN-g ELISA spot assay using a nonamer peptide se-
ries that covered the entire murine MBP sequence. The results were read
with an automated ELISA spot image analyzer. The medium background
in this experiment was 6 6 3 spots. Because no significant spot formation
(SI , 2) was seen with peptides 1–9 to 69–77 or 89–97 to 183–191, these
results are represented in a single bar. The results shown are from one ex-
periment, which was reproduced four times. (B) MHC restriction of pep-
tide 79–87. A shiverer mouse–derived 79-87–specific T cell hybridoma
2G9.4 was tested in the presence of the indicated MHC-disparate APC.
The inserted table shows the MHC alleles expressed by these APC, which
were either spleen cells from H-2 recombinant mice or the I-Ak transfected
cell line, C3F6. IL-2 production was measured by the CTLL assay.
Figure 2. Functional avidity of the MBP:79-87–specific T cell reper-
toire induced by immunization with this peptide. (A) Dose–response
curves of peptide-induced IFN-g production in freshly isolated draining
LN cells as measured by ELISA spot. Shiverer mice (open symbols) and
C3H mice (filled symbols) were immunized with the dose of MBP:79-87
peptide indicated (in CFA, subcutaneously) and tested on day 9 for the
frequency of IFN-g–producing cells at various concentrations of the pep-
tide. Data shown are mean 6 SD of triplicate wells from individual mice.
Where not visible, the SD where smaller than the size of the symbols.
Unimmunized or HEL-immunized mice did not respond to this peptide
by cytokine production or proliferation (data not shown). These data are
fully representative of 16 individual mice of both strains tested in four in-
dependent experiments. (B) Response characteristics of MBP:79-87–spe-
cific T cell hybridomas from shiverer (open symbols) and C3H mice (filled
symbols). Mice were immunized with MBP:79-87 as in A; day 9 LN cells
were fused and cloned as described in Materials and Methods. Individual
T cell hybrid clones with characteristic response patterns are shown as
measured in CTLL proliferation assays using C3H spleen cells as APC.2059 Targoni and Lehmann
Conclusions about the functional avidity of the MBP:
79-87 peptide-specific repertoires in shiverer and C3H
mice can be drawn from the data in Fig. 2 A (along with
the peptide dose required for immunization). T cell activa-
tion (including the induction of cytokine production) oc-
curs when a critical number of MHC–peptide ligands is
available for the TCR binding (25), a number that is de-
pendent on the TCR’s intrinsic affinity for this MHC–
peptide complex (26) and that can be modulated by varia-
tions in TCR and/or coreceptor densities (27). Following
the classic definition of avidity for polyvalent ligand-recep-
tor interactions, functional T cell avidity can be defined as
the concentration of peptide that leads to half the maximal
activation of T cells in a given population for a constant
number of APCs. According to this definition, the func-
tional avidity of the T cell response in shiverer mice was at
least three orders of magnitude greater than that in C3H
mice. MBP:79-87–reactive T cells yielded identical dose
response curves when activated by APCs derived from
C3H and shiverer mice (data not shown); this shows that
the differences in the responses do not reflect differences in
the APC compartment but in the avidity of the T cells
themselves. These data strongly argue for the functional in-
activation of the high avidity MBP:79-87–reactive T cell
repertoire in the MBP-bearing mice.
Using a third independent approach to assess and com-
pare the avidity of MBP-reactive T cells in shiverer and
C3H mice, we studied the dose response characteristics of
MBP:79-87–reactive T cell hybridomas generated from
both mouse strains. Fusing T cells from mice immunized
with 50 mg MBP:79-87, we obtained 346 hybrid clones
from shiverer mice and seven hybrid clones from C3H
mice (a number that reflects the frequency of peptide-reac-
tive T cells detected in the freshly isolated draining LN,
Fig. 2 A). All seven T cell hybridomas from C3H mice re-
quired concentrations of MBP:79-87 in excess of 1025 M
to be activated (Fig. 2 B). In contrast, the 25 shiverer
mouse T cell hybridomas that we randomly selected for
closer characterization fell into three categories. Nine of
these clones were triggered by peptide concentrations as
low as 10210 M, as exemplified in Fig 2 B by clone 2G9.4.
Seven clones responded only to peptide concentrations in
excess of 1026 M (exemplified in Fig. 2 B by clone 1B2.5).
The third type of clone (9 of 25) showed intermediate re-
sults similar to those seen with the clone 3D8.5 shown in
Fig. 2 B. According to Tonegawa’s algorithm (26), which
stipulates that the peptide concentrations at which T cell
activation occurs is inversely proportional to the hybri-
doma’s TCR affinity, the differences in the concentrations
required to activate the clones reflect differences in the af-
finity of the clones, while the plateau, because of the limi-
tations in this assay, reflects the maximum CTLL prolifera-
tion rather than the maximum production of IL-2.
Importantly, the T cell hybrids from all three categories
and from both mouse strains responded comparably to
anti-CD3 stimulation. Because of the similarity of these re-
sponses to antibody-mediated TCR ligation, and because
these cells were grown under the same conditions, in long-
Figure 3. Recognition of naturally processed MBP and the MBP:79-
87 peptide after immunization with this peptide. (A) The IFN-g–recall
response in primary draining LN cells measured by ELISA spot. Shiverer
or C3H mice were immunized with 50 mg MBP:79-87 and tested on day
9 for reactivity to the peptide (5 3 1025 M) and to MBP (50 mg/ml). The
data show responses of individual mice and are fully representative of 20
mice tested in five experiments. (B) The IL-2 response of mMBP:79-87–
reactive T cell hybridomas. Hybridoma clones generated from MBP:79-
87–immunized shiverer or C3H mice (see legend to Fig. 2 A and the
text) were tested in a standard CTLL assay for their response to 5 3 1025
M of peptide 79–87 and 50 mg/ml mMBP protein. Two response patterns
were seen in shiverer mice, represented by clones 2G9.4 and 3D8.5, re-
spectively. All seven C3H-derived clones displayed the response pattern
of the 2G8.10 clone shown. The same results were obtained in A and B
when the MBP concentration was increased by as much as 10-fold, to 500
mg/ml (data not shown).2060 T Cell Repertoire in MBP1/1 and MBP2/2 Mice
term culture and in the absence of MBP, which could have
affected their function, the differences in their MBP:79-87
response characteristics could not have resulted from differ-
ences in the functional states of the cells, but must reflect
differences in TCR-affinities for this peptide. The fact that
the repertoire of T cell hybridomas obtained from shiverer
mice consists of clones with high, intermediate, and low
avidities is consistent with the notion that this repertoire
has not undergone negative selection. In contrast, the fact
that only low avidity T cell hybrids were obtained from
C3H mice points towards a repertoire that has been de-
pleted of precursor cells that have high and intermediate
avidity for MBP:79-87.
MBP:79-87 Is a Cryptic Determinant in the MBP1/1 Mice.
We tested freshly isolated MBP:79-87 peptide-primed T
cells and the T cell hybridomas obtained after immuniza-
tion with this peptide to see if they could be stimulated by
the native MBP protein. In shiverer mice, the peptide-
primed primary cells gave a vigorous recall response when
cultured with MBP the magnitude of which was compara-
ble to the response recalled by the peptide itself (Fig. 3 A).
Similarly, 12 of the 25 T cell hybridomas obtained from
these mice responded to the protein as well as the peptide,
as exemplified in Fig. 3 B by clone 2G9.4. The remaining
thirteen shiverer-derived clones were stimulated only by
the peptide, as was the clone 3D8.5 in this figure. In C3H
mice, the MBP:79-87 peptide-induced response was not
recalled by mMBP when freshly isolated cells were tested
(Fig. 3 A) and none of the seven hybridomas obtained from
such immunization was stimulated by the native antigen
(Fig. 3 B). Because the MBP:79-87–specific repertoire in
shiverer mice consisted of clones that recognized type-A
and type-B conformations (28) of the MBP:79-87 determi-
nant, these data also suggest that the repertoire of these
mice had not been negatively selected. (The type-B con-
formation is assumed only when the peptide directly binds
to MHC molecules on the cell surface; type-A conforma-
tion is assumed after natural processing of protein.) In con-
trast, the MBP:79-87–reactive repertoire in C3H mice was
heavily biased towards the recognition of the type B deter-
minant.
Discussion
The extent to which homologous self peptides contrib-
ute to the positive selection of T cells has been controver-
sial. Early experiments suggested that the selecting peptide
for a given T cell might need to be related in sequence to
the antigenic peptide (29–31). Recently, it was demon-
strated that a CD41 T cell repertoire selected in the thymus
for a single peptide could react with an array of different
peptides (32). Similar observations were made in mice
whose thymic peptide diversity was extremely limited by
the prevalence of the CLIP peptide (33), which also sug-
gests that the peptide that triggers an immune response can
be of a sequence unrelated to that of the peptide(s) that se-
lect(s) the clone. Our data strongly support the latter no-
tion. The MBP-deficient shiverer mice responded vigor-
ously to MBP (Table 1), showing that positive selection by
endogenous MBP is not required to generate an MBP-spe-
cific repertoire. On the contrary, with all shiverer mice
tested, the response to MBP involved a three- to eightfold
greater clonal size than did the response to the “foreign”
antigens, HEL and OVA (Table 1) to both of which C3H
mice are high responders. It would seem that, if endoge-
nous lysozyme or albumin were to contribute to the shap-
ing of responses specific for HEL and OVA, it would be by
negative rather than positive selection of the preimmune
repertoires.
Although antigens like HEL and MBP include several
sequences that can bind a given class II allelic product, fre-
quently only one of these potential determinants actually
induces a response after immunization with the protein
(16). This immunodominance of a single determinant is a
poorly understood feature of T cell responses. It could be
the result of unique aspects of antigen presentation, e.g.,
MHC-guided processing (34–36), or it could be the result
of repertoire limitations imposed by the homologous au-
toantigen. For example, sequences shared by the foreign
(e.g., HEL) and self (e.g., mouse lysozyme) antigens could
contain several immunodominant determinants, but be-
cause these determinants would negatively select the reper-
toire, only a fraction of the potential determinants, those
that are species-foreign, would be available to elicit a re-
sponse. The fact that MBP2/2 shiverer mice recognize a
single determinant (Fig. 1 A) strongly argues against nega-
tive selection of the repertoire being a major defining factor
for the single-determinant dominance of this response.
On the other hand, the fact that the immunodominant
determinant in the MBP2/2 mice behaved as a cryptic de-
terminant in the MBP1/1 mice suggests that the repertoire
selected by the endogenous antigens contributes to the de-
fining of the determinant hierarchy. Unlike the situation
with foreign antigens, where peptides with the highest af-
finity for MHC are likely to be the most immunogenic
(17), with self antigens, such peptides are prone to induce
tolerance most efficiently (18, 19), thus making them ap-
pear cryptic.
Our data suggest that the determinant that is actually im-
munodominant on MBP induces profound clonal inactiva-
tion in mice that express MBP. Although immunization
with peptide MBP:79-87 triggered a response in C3H
mice, the clones induced were of low avidity (Fig. 2) and
recognized only the peptide (Fig. 3). Apparently, the vast
majority of high avidity cells capable of recognizing the en-
dogenous protein did encounter it before the immuniza-
tion and the outcome was functional inactivation. This tol-
erance might have resulted from clonal deletion or from
the induction of an anergic state, or both, possibly affecting
T cells with different avidities for MBP differently. TCR-
transgenic models using TCRs with different avidities for
MBP might be required to clearly distinguish between
these possibilities. Because MBP messenger RNA is ex-
pressed in the thymus (1–3) and because it has recently
been demonstrated that there is sufficient antigen presenta-
tion of MBP in this organ to stimulate MBP-reactive T cell2061 Targoni and Lehmann
hybridomas (4), the development of central tolerance may
account for the clonal inactivation that we observed. There-
fore, MBP does not appear to be a sequestered antigen, as
once thought, but one that causes negative selection of the
high avidity repertoire (24).
The TCR transgenic approach to studies of self tolerance
to MBP suggested that MBP is ignored by MBP-specific T
cells (5–7). Although ignorance was also seen in several
other TCR transgenic models in which neo-self antigens
were expressed in peripheral tissues (37–42), we propose that
this mechanism applies only for low avidity MBP-reactive
T cells. If the peripheral repertoire in MBP-expressing
hosts consists of T cells that have escaped negative selection
due to their low avidity for MBP (T cell clones of which
were used to construct TCR transgenic mice), the trans-
genic T cells are likely to be ignorant of the autoantigen as
well.
MBP:79-87 qualifies as cryptic determinant in C3H
mice because it does not recall a response after the immuni-
zation with native MBP (Fig. 1 A) but is immunogenic
when injected as a peptide (Figs. 2 A and 3 A). Because all
seven hybrids that we obtained from C3H mice recognized
the MBP:79-87 peptide, but not the native protein, the
MBP:79-87–reactive T cell repertoire in these mice seemed
to be biased towards recognition of the type B determi-
nant (28). It is unclear whether such T cells are capable of
mediating autoimmune pathology. For type B determi-
nants to constitute a target in the CNS there would have to
be extracellular peptide available for direct cell surface
binding to APC, and, because of the apparent low avidity
of these T cells, the concentration of endogenous free pep-
tide would need to be high.
We found C3H mice to be resistant to MBP-induced
and MBP:79-87–induced EAE when using protocols that
cause severe disease in EAE-susceptible mouse strains. Even
grafting lymphoid cells from naive shiverer mice into C3H
mice did not render C3H mice susceptible to the induction
of active disease. Neither could we induce passive disease
by injecting MBP:79-87–primed T cells from shiverer into
C3H mice, nor with primary cells or T cell lines. Although
this outcome suggests that the shiverer/C3H model might
not qualify for studies of EAE, it sends a novel and surpris-
ing message about disease susceptibility. Whereas the pri-
mary focus of research addressing susceptibility to T cell–
mediated autoimmune disease has been on the ability to
generate a vigorous type-1 response to the autoantigen
(MHC-linked Ir gene effects, T cell repertoires, type-1/
type-2 biases), these data suggest that even the most vigor-
ous, unipolarly type 1-biased T cell responses to MBP do
not cause clinical disease if they occur in a host that lacks the
genetic susceptibility to develop downstream inflammatory
pathology. In such mice, in addition to central tolerance,
powerful peripheral tolerance mechanisms seem to prevent
T cell–mediated immunopathology of the central nervous
system.
Because of the EAE-resistance of C3H mice, we could
not address the issue of whether the low avidity T cells that
escape negative selection can be pathogenic. Previous stud-
ies performed in the H-2u model might provide clues to
this question showing that peptide, MBP:121-140, a cryp-
tic determinant in MBP1/1 H-2u mice, is codominant
with MBP:Ac1-11 in the congenic MBP2/2 mice (43).
These data can be interpreted as reflecting similar avidity-
repertoire selections, as we do here. If this were the case,
the fact that MBP:121-140 is encephalitogenic in H-2u
mice (15) might be seen as evidence that negative selection
for a dominant determinant is incomplete and can cause
autoimmune pathology.
The inactivation of T cells that are specific for the domi-
nant MBP determinant is likely to occur in EAE-suscepti-
ble mice too, but even if it were as profound in those
strains as we observed it to be in C3H mice, for theoretical
reasons it is unlikely to be complete. A central question in
the understanding of autoimmune disease will be how au-
toreactive T cells that escaped negative selection and have
the autoantigen presented to them at a subthreshold level
can be induced to mediate autoimmune pathology. Like T
cell activation itself, negative selection is threshold-depen-
dent (24), that is, T cells will be deleted only if their TCRs
bind a critical number of MHC–peptide ligands, a number
defined by the affinity of the TCR for the peptide (26).
The MBP-specific clones that escape negative selection
will, therefore, fall into two broad categories: first, T cells
with receptors having a low affinity for an abundantly pre-
sented peptide (T cell crypticity); second, T cells that have
high, low and intermediate avidities for peptides that are
presented in low copy numbers on the APC (determinant
crypticity). Because the autoantigen is presented at sub-
threshold levels to both types of clones, they are ignorant of
it. This activation threshold seems to be lowered after the
naive cell is primed to a memory/effector state. Studies of
TCR-transgenic cells showed that the activation of naive T
cells requires peptide concentrations up to 50 times higher
than those needed by primed/memory T cells (44). If the
activation threshold of T cells, however, is not constant for
an individual clone but varies as a function of its state of ac-
tivation, environmental priming by cross-reactive antigens,
or by immunization in adjuvant could make the number of
endogenous MHC/peptide ligands that was substimulatory
to the naive cell stimulatory to the memory cell. The au-
toantigen that was ignored by the naive cells will be at-
tacked by the memory cells.
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